REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Damipharm s.r.o. (Slovakia)

Main Activities: Department Stores
Full name: Damipharm s.r.o. Profile Updated: January 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Damipharm s.r.o. is an enterprise in Slovakia, with the main office in Nitra. It operates in the Department Stores sector. It was established on May 24, 2007. 20 - 24 (2023) employees currently work for Damipharm s.r.o.. The latest financial highlights indicate a net sales revenue drop of 1.33% in 2022. Its’ total assets recorded a negative growth of 1.98%. In 2022, Damipharm s.r.o.’s net profit margin decreased by 8.99%.

Headquarters
Spitalska 13
Nitra; Nitriansky; Postal Code: 94901

Contact Details: Purchase the Damipharm s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Damipharm s.r.o. report to view the information.
Outstanding Shares:
Purchase the Damipharm s.r.o. report to view the information.
Registered Capital:
Purchase the Damipharm s.r.o. report to view the information.
Incorporation Date:
May 24, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Damipharm s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.33%▼
Total operating revenue
-3.25%▼
Operating profit (EBIT)
-81%▼
EBITDA
-66.55%▼
Net Profit (Loss) for the Period
-80.9%▼
Total assets
-1.98%▼
Total equity
3.56%▲
Operating Profit Margin (ROS)
-10.96%▼
Net Profit Margin
-8.99%▼
Return on Equity (ROE)
-15.19%▼
Debt to Equity Ratio
-5.07%▼
Quick Ratio
0.91%▲
Cash Ratio
2.15%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo